One completely ordinary glass of wine.
Then suddenly you’re awake at 3 a.m., your heart is racing, you’re hot, your sleep is wrecked, your stomach feels off—and the next morning feels suspiciously like a hangover that should have required a much bigger night out.
Sound familiar?
In this episode of The Modern Midlife Collective, Dr. Jillian and Dr. Ade explore why many women notice that alcohol affects them differently during perimenopause and menopause.
And while hormones are part of the conversation, the answer is much more nuanced than “your estrogen dropped.”
Alcohol is landing in a body that may now have different body composition, total body water, sleep architecture, medications, metabolic demands and nervous-system vulnerability—all while estrogen is becoming increasingly unpredictable during the menopause transition.
This episode is about recalibration, not perfection.
No shame. No judgment. No gold stars for abstinence.
Just better information.
IN THIS EPISODE
Dr. Jillian and Dr. Ade discuss:
- Why alcohol may suddenly feel stronger in midlife
- Why perimenopause is better described as hormonal turbulence than a simple estrogen decline
- How alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH2) metabolize alcohol
- Why genetic differences can dramatically affect alcohol tolerance
- How lower total body water can contribute to higher blood-alcohol concentrations
- Age-related changes that may affect the “bounce-back”
- Why alcohol may make you sleepy while still disrupting restorative sleep
- REM sleep and those notorious 3 a.m. awakenings
- “Hangxiety” and the nervous-system rebound after alcohol
- Alcohol as a potential hot-flash or night-sweat trigger
- Why different drinks may feel different—even though ethanol is still ethanol
- Histamine, sulfites and why red wine may suddenly make some women miserable
- Why “red wine is good for your heart” deserves more nuance
- Alcohol and breast-cancer risk
- Alcohol’s effects on appetite, weight-management goals and training recovery
- What to consider if you are taking a GLP-1 medication
- Bladder urgency, frequency and menopause-related genitourinary symptoms
- Why new medications may change your alcohol tolerance
- What we know—and still don’t know—about alcohol and the gut microbiome
- Hormonal and evidence-based nonhormonal options for bothersome hot flashes and night sweats
- The Two-Week “Does Alcohol Actually Like Me?” Experiment
KEY TAKEAWAYS
1. It probably isn’t just one hormone.
Estrogen and alcohol do interact, and research has found associations between alcohol exposure and estradiol levels. But current evidence does not support reducing midlife alcohol intolerance to a simple story in which fluctuating estrogen directly “switches off” ADH or ALDH2.
Aging, genetics, body composition, sleep, medications, liver physiology and the menopause transition can all overlap.
2. The same drink may be landing in a different body.
Alcohol distributes through body water. Changes in body composition with aging—including loss of lean tissue when muscle is not actively preserved—can change the physiologic context in which alcohol is consumed.
That is one more reason strength training, protein intake and maintenance of lean mass matter in midlife.
3. Being able to “hold your liquor” doesn’t make alcohol harmless.
Tolerance describes how intoxicated you feel. It does not mean other physiologic effects disappear.
Tolerance describes how intoxicated you feel. It does not mean other physiologic effects disappear.
4. Alcohol may help you fall asleep—but that doesn’t make it a sleep treatment.
A 2025 systematic review and meta-analysis of 27 studies found that alcohol altered sleep architecture, including delayed REM onset and reduced REM sleep. REM disruption was seen even at relatively low doses and worsened as alcohol intake increased. (PubMed)
A 2025 systematic review and meta-analysis of 27 studies found that alcohol altered sleep architecture, including delayed REM onset and reduced REM sleep. REM disruption was seen even at relatively low doses and worsened as alcohol intake increased. (PubMed)
5. Red wine is not cardiovascular medicine.
Some observational studies historically suggested cardiovascular benefits from light-to-moderate alcohol use, but newer analyses have challenged a clear protective effect. The American Heart Association advises people who do not currently drink not to start drinking for health benefits. (professional.heart.org)
6. Alcohol and breast-cancer risk deserve an honest conversation.
Alcohol is a known human carcinogen. NIAAA currently notes that even approximately one drink per day is associated with a 5% to 15% higher breast-cancer risk compared with women who do not drink.
That statistic describes population-level risk. It does not mean one glass of wine “causes” breast cancer in an individual woman. It is information women deserve when deciding what level of alcohol exposure feels acceptable to them. (NIAAA)
7. Know what “one drink” actually means.
In the United States, one standard drink contains approximately 14 grams of pure alcohol:
- 12 oz regular beer at about 5% ABV
- 5 oz wine at about 12% ABV
- 1.5 oz distilled spirits at about 40% ABV
A cocktail, restaurant pour or large home wine glass may contain more than one standard drink. (NIAAA)
8. You do not have to simply tolerate disruptive hot flashes.
Hormone therapy remains the most effective treatment for bothersome vasomotor symptoms for appropriate candidates. Women who do not want—or are not candidates for—hormone therapy also have evidence-based nonhormonal choices. (The Menopause Society)
Hormone therapy remains the most effective treatment for bothersome vasomotor symptoms for appropriate candidates. Women who do not want—or are not candidates for—hormone therapy also have evidence-based nonhormonal choices. (The Menopause Society)
Newer nonhormonal options include neurokinin-targeting therapies. Fezolinetant is FDA approved for moderate-to-severe menopausal hot flashes and carries a boxed warning regarding rare serious liver injury. Elinzanetant received FDA approval on October 24, 2025, for moderate-to-severe vasomotor symptoms due to menopause. (U.S. Food and Drug Administration)
THE TWO-WEEK “DOES ALCOHOL ACTUALLY LIKE ME?” EXPERIMENT
For 14 days, eliminate alcohol—or reduce it enough to create a meaningful comparison.
Track:
1. Sleep quality
How quickly did you fall asleep? Did you stay asleep? How rested were you the next morning?
2. Hot flashes/night sweats
Frequency, intensity and nighttime awakenings.
3. Morning energy
Clearheaded? Sluggish? Headache? Puffy?
Clearheaded? Sluggish? Headache? Puffy?
4. Mood/anxiety
Calm? Irritable? Low? Wired? Anxious?
Calm? Irritable? Low? Wired? Anxious?
5. Appetite/cravings
Did hunger, sugar cravings or food choices change?
Did hunger, sugar cravings or food choices change?
If you choose to drink again after the experiment, simply observe what happens.
No moral judgment.
Just data.
IF YOU CHOOSE TO DRINK
Consider:
- Avoid drinking on an empty stomach.
- Know the difference between a glass and a standard drink.
- Slow the pace.
- Hydrate and alternate with nonalcoholic beverages.
- Consider finishing alcohol earlier in the evening rather than immediately before bed.
- Pay attention to which beverages seem to trigger symptoms.
- Review potential medication interactions with your pharmacist or prescribing clinician.
And ask yourself one more question:
Why am I pouring this drink?
Because you genuinely enjoy it?
Because you’re celebrating or socializing?
Or because it has become your primary treatment for insomnia, stress, anxiety, loneliness or hot flashes?
If alcohol has become the way you have to sleep, relax or cope, that deserves a compassionate conversation with your healthcare professional.
SIGNS THAT DESERVE MEDICAL EVALUATION
Talk with your healthcare professional if alcohol is associated with concerning symptoms such as severe flushing, hives, wheezing, swelling, fainting or significant palpitations.
Persistent gastrointestinal symptoms—including blood in the stool, unexplained weight loss, progressive abdominal pain or major changes in bowel habits—also deserve evaluation rather than being automatically attributed to menopause or “gut health.”
Medication-alcohol interactions can also be clinically important, particularly with sedating medications. Ask your pharmacist or prescriber about your individual medications.
RESOURCES & FURTHER READING
National Institute on Alcohol Abuse and Alcoholism — Women and Alcohol
Breast-cancer risk, alcohol-related blackouts and sex-related vulnerabilities.
NIAAA: Women and Alcohol
Breast-cancer risk, alcohol-related blackouts and sex-related vulnerabilities.
NIAAA: Women and Alcohol
NIAAA — What Is a Standard Drink?
Standard U.S. drink equivalents and alcohol content.
NIAAA: What Is a Standard Drink?
American Heart Association — Alcohol Use and Cardiovascular Disease
Current cardiovascular guidance and evidence summary.
AHA: Alcohol Use and Cardiovascular Disease
Gardiner et al. — The Effect of Alcohol on Subsequent Sleep in Healthy Adults
Systematic review and meta-analysis examining alcohol dose, timing and sleep architecture.
PubMed: Alcohol and Subsequent Sleep Meta-analysis
Systematic review and meta-analysis examining alcohol dose, timing and sleep architecture.
PubMed: Alcohol and Subsequent Sleep Meta-analysis
Handy, Greenfield & Payne — Estrogen and Alcohol Use in Women
Targeted review examining the relationship between estradiol and alcohol exposure across women’s lives.
PubMed: Estrogen and Alcohol Use in Women
The Menopause Society — Hormone Therapy
Evidence-based information about hormone therapy and vasomotor-symptom treatment.
The Menopause Society: Hormone Therapy
The Menopause Society — 2023 Nonhormone Therapy Position Statement
Evidence review of nonhormonal approaches to vasomotor symptoms.
The Menopause Society: Nonhormone Therapy Position Statement
Evidence review of nonhormonal approaches to vasomotor symptoms.
The Menopause Society: Nonhormone Therapy Position Statement
FDA — Veozah/Fezolinetant Safety Communication
Current information regarding rare serious liver injury and required monitoring.
FDA: Veozah Safety Information
FDA — Lynkuet/Elinzanetant
FDA information following its October 24, 2025 approval for moderate-to-severe vasomotor symptoms due to menopause.
FDA: Lynkuet Drug Trials Snapshot
Midlife asks us to renegotiate a lot of things: how we sleep, train, eat, recover, manage stress—and sometimes how we drink.
You don’t have to keep proving that you can tolerate something simply because you could tolerate it at 28.
Your body changed.
Update the plan.
Update the plan.
Because sometimes thriving at 40 and beyond looks a lot less like getting better at “bouncing back” and a lot more like finally knowing what you don’t need to recover from.
MEDICAL DISCLAIMER
The information shared on The Modern Midlife Collective Podcast is for educational and informational purposes only. Although we are licensed medical professionals, the content shared is not a substitute for personalized medical advice, diagnosis, or treatment. Listening to this podcast does not establish a provider-patient relationship. Please consult your own healthcare provider before making any medical or wellness decisions.